SCHEMBL21854732

SCHEMBL21854732

CNC(=O)[C@@H]1CNCCN1C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.51
PTPN1 P18031 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TSHR P16473 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
CTSK P43235 2/20 0.47
GFER P55789 1/20 0.47
CTRB1 P17538 1/20 0.47
CTSB P07858 1/20 0.46
CTSS P25774 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PREP P48147 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 2/20 0.46
TP53 P04637 1/20 0.46
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8707997 0.88 NPSR1 (0.49) HTR2CNPSR1TSHRL3MBTL1KDM4E
SCHEMBL3017853 0.87 HTR2C (0.52) HTR2CNPSR1TSHRL3MBTL1KDM4E
SCHEMBL6487292 0.87 HTR2C (0.52) HTR2CNPSR1TSHRL3MBTL1KDM4E
SCHEMBL6501753 0.87 HTR2C (0.52) HTR2CNPSR1TSHRL3MBTL1KDM4E
SCHEMBL1257136 0.87 HTR2C (0.50) HTR2CNPSR1TSHRL3MBTL1KDM4E
SCHEMBL7251746 0.87 HTR2C (0.53) HTR2CNPSR1TSHRL3MBTL1CTRB1
SCHEMBL8220722 0.87 HTR2C (0.53) HTR2CNPSR1TSHRL3MBTL1CTRB1
Hydrochloric Acid SCHEMBL7013165 0.86 HTR2C (0.51) HTR2CNPSR1TSHRL3MBTL1KDM4E
SCHEMBL4674934 0.85 HTR2C (0.52) HTR2CNPSR1CTRB1PREPNPC1
SCHEMBL12479521 0.84 SMN1; SMN2 (0.53) HTR2CNPSR1TSHRL3MBTL1CTRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081917-A1 ΒETA-CATENIN AND B-CELL LYMPHOMA 9 (BCL9) INHIBITORS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2020-04-23 WO disclosed